DrugPatentWatch Database Preview

Details for Patent: 7,700,076

Which drugs does patent 7,700,076 protect, and when does it expire?

Patent 7,700,076 protects FINACEA and is included in one NDA.

This patent has one hundred and thirty-three patent family members in nineteen countries.

Summary for Patent: 7,700,076

Title:	Penetrating pharmaceutical foam
Abstract:	The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.
Inventor(s):	Tamarkin; Dov (Maccabim, IL), Friedman; Doron (Karmei Yosef, IL), Eini; Meir (Ness Ziona, IL)
Assignee:	Foamix, Ltd. (Ness Ziona, IT)
Application Number:	10/922,358
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,700,076
Patent Claim Types: see list of patent claims	Composition; Compound; Delivery;

Drugs Protected by US Patent 7,700,076

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Bayer Hlthcare	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 7,700,076

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Israel	152486	Oct 25, 2002

Non-Orange Book US Patents Family Members for Patent 7,700,076

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
7,820,145	Oleaginous pharmaceutical and cosmetic foam	➤ Sign Up
9,211,259	Antibiotic kit and composition and uses thereof	➤ Sign Up
9,101,662	Compositions with modulating agents	➤ Sign Up
9,265,725	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 7,700,076

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2003279493	➤ Sign Up
Australia	2004261063	➤ Sign Up
Australia	2004266502	➤ Sign Up
Australia	2004313285	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 7,700,076

Foreign Priority and PCT Information for Patent: 7,700,076

For more information try a trial or see the plans and pricing